‹

News & Bulletin UpdatesNews

INDIA DOMESTIC PRICES – WHAT IS GOING ON?

C5 prices in India edge up this week but trail last month – India Domestic Prices – What Is Going On?

IndianPetroChem

This edition covers:

  • Methanol prices in India dip this week but stay above last month
  • Dimethylformamide prices in India fall sharply, extending a steep fortnight decline
  • IPA prices in India drop this week but edge above last month
  • Benzene prices in India rise again, climbing sharply above last month
  • Vinyl acetate monomer prices in India slip this week but firmer monthly
  • Ethyl acetate prices in India rise again, nearing a recent high
  • C5 prices in India edge up this week but trail last month
  • Nitrobenzene prices in India fall this week but stay above month
  • Lauric acid prices in India rise again, nearing a fresh recent high
  • Palm wax prices in India dip this week, easing from last month
  • Stearic acid prices in India dip this week but stay firmer monthly
  • Glycerine prices in India dip this week but stay above fortnight
  • Monostearin prices in India surge to a fresh one-year high
  • Acrylamide prices in India fall again, extending a month-long decline
  • Caustic soda flakes prices in India fall sharply on a steep monthly drop
  • Paraformaldehyde prices in India rise again on strong monthly gains
  • Maleic anhydride prices in India fall again on a steep monthly drop
  • Hydrogen peroxide prices in India dip this week but firmer monthly
  • Heavy soda ash prices in India edge up but trail three months
  • Mancozeb prices in India climb steadily on strong fortnight gains
  • PP prices in India hold steady this week, firmer than last month
  • PBT prices in India dip this week but hold flat monthly
  • ABS prices in India hold steady this week, firmer than last month
  • SEBS 751 prices in India climb to a fresh recent high
  • PBR 1220 prices in India ease this week but stay firmer monthly

The complete bulletin is available to subscribers.

Read the complete bulletin

Request a free trial and our team will set up your access. Subscribers log in and return to this bulletin in full.

Questions about access? Contact our team
← Browse more news & analysis